Navigation Links
Focus on DNA transcription

Biological chemists at the University of north Carolina at Chapel Hill, state about the discovery of how living organisms convert genetic instructions into action.

The UNC scientists have found a previously unknown chemical site on a key enzyme that regulates production of the genetic messenger known as RNA. When the chemical site is occupied, it markedly speeds up the// process by which the information contained in DNA,is converted into functions critical for maintaining life.

A report authored by Dorothy .A. Erie, Assitant Professor in Chemistry and her team say that " the information for all the genes in an organism is containd in its DNA.For this information to be translated into function, sections of the DNA must be copied into an RNA chain. The RNA is then translated ino proteins that must carry out particular functions such as wound healing which is at the end of a complicated cascade of events in the body.

Transcription is the process of making RNA chains from DNA.In a series of complicated experiments with the enzyme from the bacteria E.Coli. Erie and her students found that when the precursor molecule does not occupy the newly discovered site, the enzyme copies the DNA slowly.When the molecule occupies the site, producton of RNA kicks into overdrive.The process than occurs about 10 times faster than it would otherwise.

"Such rapid synthesis is essential for proper cellular function.The discovery of this additional binding site will change the view of how transcription is regulated in the cell" Erie said.She further added that many cancers involve over or improper expression of genes and some are regulated at the level of transcription.Knowing now that there are two binding sites on the enzyme instead of one will enable scientists to interpret data they collect much more accurately.


'"/>




Page: 1

Related medicine news :

1. Focused Treatment For Childhood Cancer
2. Focussed treatment for Hodgkins disease
3. World Heart Day To Focus On Ideal Body Weight And Shape To Reduce Risk Of Heart Disease
4. Now Employers Focus On Employees Mental health
5. A New Focus For The Mechanism Of Nerve Growth
6. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
7. UN research symposium To Focus on Open source and Open Medicine
8. Biocon To Shift Focus On Innovation To Accelerate Growth
9. UK Has To Focus On Bridging the Gap between Healthcare Professionals and Patients
10. The Australian Medical Association To Focus On Health Of Aborigines
11. Ritalin Could Help In Focussing The Mind
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Focus DNA transcription

(Date:5/16/2008)...kard, from Griffiths School of Nursing and Midwife...the HESTA Australian Nursing Awards. , Professo...patient blood loss during testing procedures, redu...ansfusions among already ill patients. The award w...rnes Crown Entertainment complex. , Nurses rout...
(Date:5/16/2008)...on Public Service Announcement Available, RADNOR,...ition of,National Mental Health Month and Older Pe...n Council (SPC) will offer an important message to...ment. The public service,announcement developed by...o the public health problem of depression and to o...
(Date:5/16/2008)... appointment of Nomura Code Securities Limited as ...r, NEW YORK, May 16 /PRNewswire-FirstCall/ -- Med...ts, Inc. (Amex: MGT ) (the "Company"), and an,ind...Detection (CAD) and,image analysis software which ...sease, today announced the appointment of NM Roths...
(Date:5/16/2008)...16 /PRNewswire/ -- Barbara Senich, B.S.N., M.B.A.,... Services, was honored by,Executive Women of New J...2008 Awards Dinner. The biennial event, held May 1...ized women of professional distinction in New,Jers...of directors at major,New Jersey-based corporation...
Breaking Medicine News(10 mins):Health News:Research talent wins national Innovation in Nursing award 2Health News:Suicide Prevention Group Delivers Much-Needed Message to Pennsylvania's Elderly 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3
...ident, Dr Mukesh Haikerwal, today urged all Austra...eir families about their desire to donate organs./... of Australia has revealed that organs for transpl... a fraction of the nation’s potential donors. The...
...(R) in PEPCHF Trial, has been the first agent to d...ure patients with diastolic dysfunction.// The dr...s toelderly people with chronic heart failure acco...CE inhibitor Coversyl(R) that was presented at the...
...ortunities for organ donation are being missed in ...on rates that are among the lowest in the Western ...test edition of the Medical Journal of Australia (...lvester, Intensive Care Specialists at Austin Heal...
... bracing itself for an outbreak of the deadly bird...and Sohaj governorates.// The first of these cases... Sohag province, some 490 kilometers or 305 miles ...ng this report all poultry on the farm were slaugh...
Other Medicine News:Health News:AMA Urges Organ Donors to Speak Up 2Health News:Coversyl Demonstrates Clinical Benefits in Elderly Patients 2Health News:Lost Opportunities for Organ Donation 2
(Date:5/15/2008)...5 /- Ergonex Pharma today,announced t... (FDA) has,granted orphan drug designation to Terg...rtension (PAH). Terguride is currently being evalu...., "The FDA,s grant of orphan drug designation to...development program by offering regulatory,clinic...
(Date:5/15/2008).../- Tigris Pharmaceuticals,Inc. annou... and,Development Agreement (CRADA) with the Nation...al and preclinical development of AFP-464, an,amin... is converted to,metabolites which bind covalently...., This is part of a four-year CRADA encompassing...
(Date:5/15/2008)...for an Antiplatelet Therapy that, Combined, with A...of Plavix/Iscover and Aspirin, According to a ...., May 15 /- Decision Resources, one ... for pharmaceutical and,healthcare issues, finds t...ovement in patient compared to Sanofi-Aventis/Bris...
(Date:5/15/2008)...er CEA Trial data reports in third quarter ...15 /- VIA Pharmaceuticals,...used on the development of,compounds for the treat...at,it has completed patient enrollment in its acut...one of three Phase 2 trials investigating VIA-2291...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 1Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 2Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 3Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 4Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 5Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 1Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 2Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 3Anesiva Raises 2445 Million in Common Stock Offering 2178 1Anesiva Raises 2445 Million in Common Stock Offering 2178 2Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 1Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 2Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 3
...ly 9, 2007 - NexMed, Inc.,(NASDAQ: NEXM), a develo...the NexACT(R) drug delivery technology, today anno...t enrollment for Phase,III clinical trials for NM1... fungus). Pursuant to the terms of the licensing,a... a milestone,payment early next year. NexMed enter...
... 2007 - Neurologix, Inc.,(OTCBB:NRGX), a biotechno...ive gene therapies for the brain and central nervo...resent at the Third Annual,C.E. Unterberg Towbin E... at 4:30 pm ET at The Mandarin Oriental Hotel in N...hn Mordock will discuss,Neurologix,s business and ...
Other Medicine Technology:NexMed Announces Completion of Patient Enrollment in Two Pivotal,Phase 3 Studies for Anti-Fungal Product 2
Cannulated Interference Screws
IEC-Innovative Endoscopy Components, LLC offers high quality Arthroscopy Medical Equipment "Made in Germany". All our Arthroscopes are manufactured according to ISO 9001 standards, featuring the most
The New Digital Recording System From Luxtec,The new MicroLux Digital Video Recorder gives you an entirely new way to visualize, edit, share and store your surgical cases.
...ition is achieved using an increased tilt angle of.... The patient preparation can be carried out outsi...patient can be brought rapidly outside the shielde...ated neck support increases patient safety and com...
Medicine Products: